headquartered in Rockville, MD, is an award-winning Contract Research Organization (CRO) focused primarily in early phase oncology, vaccines, and general medicine. As a clinical services provider to the pharmaceutical and biotechnology industries, Accelovance offers comprehensive clinical development services including management and implementation of Phase I-IV clinical trials and a Clinical Call Center used for recruitment, post-marketing surveillance, and long-term survival follow-up. For more information, visit the company’s Web site at http://www.accelovance.com.
Press Contact: Michael Keens, VP Business Development
Logo – http://photos.prnewswire.com/prnh/20140219/DC68221LOGO
Web Site: http://www.accelovance.com
Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth